Citadel Advisors - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$5,345,000
-12.2%
155,151
-57.4%
0.00%0.0%
Q2 2020$6,087,000
+0.4%
364,315
-13.4%
0.00%
-33.3%
Q1 2020$6,065,000
-57.7%
420,701
-1.8%
0.00%
-50.0%
Q4 2019$14,338,000
+31.9%
428,393
-17.5%
0.01%
+20.0%
Q3 2019$10,871,000
+35.5%
519,171
+34.7%
0.01%
+25.0%
Q2 2019$8,025,000
+59.9%
385,416
+71.6%
0.00%
+100.0%
Q1 2019$5,020,000
-24.7%
224,635
-19.4%
0.00%
-50.0%
Q4 2018$6,668,000
+311.4%
278,779
+369.2%
0.00%
Q3 2018$1,621,000
-24.5%
59,415
-25.6%
0.00%
-100.0%
Q2 2018$2,148,000
+157.9%
79,891
+205.3%
0.00%
Q1 2018$833,000
-4.8%
26,164
+13.1%
0.00%
-100.0%
Q4 2017$875,000
-93.7%
23,133
-95.9%
0.00%
-90.9%
Q3 2017$13,873,000
+3753.6%
559,641
+3092.5%
0.01%
Q2 2017$360,000
-49.5%
17,530
-49.7%
0.00%
-100.0%
Q4 2016$713,000
+180.7%
34,868
+105.8%
0.00%
Q3 2016$254,000
+36.6%
16,944
-1.6%
0.00%
Q2 2016$186,00017,2230.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders